On March 4, 2025, a scientific and practical conference "Immunotherapy and immunoprophylaxis of eye infections" was held in the lecture hall of the Department of Ophthalmology of ONMU. The role of immune peptides in overcoming resistance to common antibiotics was discussed in his report by Serhii Konovalenko, Ph.D., immunologist. The immune peptides in the composition of Arecur eye balm, due to their pronounced anti-infective properties, effectively destroy pathological biofilms that are formed due to the weakening of the conjunctival mucosa local immunity. The speaker also emphasized that the effect on the activity of Tlymphocytes and macrophages of tear fluid, as well as the stimulation of the synthesis of secretory immunoglobulin A - the main weapon against pathogens - determines the anti-relapse effect of immune peptides in Arecur eye balm.

In her speech, the head of the immunology laboratory of the State Institution "V.P. Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine", Doctor of Medical Sciences Liudmyla Velychko focused the audience's attention on the extremely important characteristics of immune peptides, namely, the ability to create unfavorable conditions for the reproduction of herpes viruses, which affect not only the mucous membrane but also the cornea, as well as the characteristic effect of immunocorrection - the adjustment of local immunity to effectively counteract the infectious process. L. Velychko emphasized that not only immunotherapy, but also timely and complete prevention of exacerbations of herpetic eye infections can prevent threatening complications, in particular, significant deterioration and even loss of vision.

Doctor of Medical Sciences, Professor, Head of the Department of Ophthalmology of ONMU Natalia Konovalova agreed with her colleagues, and also cited several clinical examples when the insensitivity of eye infection pathogens to etiotropic therapy led to chronic inflammation and frequent relapses. N. Konovalova noted that due to the lack of population resistance of pathogens to immune peptides in Arecur eye balm, significant prospects for clinical application open up. Professor thanked the International Biotherapy Institute and personally the general director of the institution, PhD, oncologist, Oleksii Tatskyy, for the scientific and organizational support of the conference.

Summing up the conference, O. Tatskyy thanked his colleagues for presenting meaningful and vivid reports and assured the participants of the event that new scientific meetings will be initiated in the foreseeable future to discuss current issues of immunotherapy.